Alto Ingredients, Inc.
Qualité des données : 100%
ALTO
NASDAQ
Manufacturing
Chemicals
4,85 €
▼
0,25 €
(-4,86%)
Cap. Boursière: 372,80 M
6 months return
—
Momentum
Neutral
ROE
6,20%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Debt/Equity of 0,48 — conservative balance sheet
Generating 8,65 M in free cash flow
Capital efficient — spends only 0,50% of revenue on capex
ROIC of 2,11% — low return on invested capital
Interest coverage of 0,68× — tight debt servicing
Price History
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-4,90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
6,20%
Au-dessus de la moyenne du secteur (-54,44%)
ROIC2,11%
Net Margin1,45%
Op. Margin0,80%
Sécurité
Debt / Equity
0,48
Au-dessus de la moyenne du secteur (0,30)
Current Ratio3,56
Interest Coverage0,68
Valorisation
PE (TTM|NTM|2027)
27,95 | 12,63 | 12,68
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio1,68
EV/EBITDA13,70
Dividend YieldN/A
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 28,0 | -1,5 |
| P/B | 1,7 | 1,6 |
| ROE % | 6,2 | -54,4 |
| Net Margin % | 1,5 | -41,5 |
| Rev Growth 5Y % | — | 1,7 |
| D/E | 0,5 | 0,3 |
Objectif de Cours des Analystes
2 analystes
Consensus des analystes : objectif moyen vs prix actuel et notation.
Buy
Actuel
4,85 €
Objectif
6,75 €
5,50 €
6,75 €
8,00 €
Prévisions
P/E Prévisionnel
12,63
BPA Prévisionnel
0,38 €
Croissance BPA (est.)
+28,8%
CA Est.
964,04 M
Estimations de Bénéfices
Prévisions d’EPS et de chiffre d’affaires par période. Annuel = exercices ; trimestriel = prochains trimestres.
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,38 €
0,35 € – 0,41 €
|
964,04 M | 2 |
| FY2026 |
0,30 €
0,19 € – 0,40 €
|
959,90 M | 2 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
0,12 €
0,07 € – 0,16 €
|
246,28 M | 2 |
| 2026 Q1 |
-0,03 €
-0,08 € – 0,02 €
|
215,67 M | 2 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,06 € | 0,16 € | +364,3% |
| Q32025 | -0,06 € | 0,16 € | +393,0% |
| Q22025 | -0,11 € | -0,13 € | -23,2% |
| Q12025 | -0,20 € | -0,19 € | +7,4% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,90% | Revenue Growth (3Y) | -13,36% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | -26,65% |
| Profitability | |||
| Revenue (TTM) | 917,93 M | Net Income (TTM) | 13,34 M |
| ROE | 6,20% | ROA | 3,41% |
| Gross Margin | 3,80% | Operating Margin | 0,80% |
| Net Margin | 1,45% | Free Cash Flow (TTM) | 8,65 M |
| ROIC | 2,11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,48 | Current Ratio | 3,56 |
| Interest Coverage | 0,68 | Asset Turnover | 2,35 |
| Working Capital | 108,50 M | Tangible Book Value | 214,67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 27,95 | Forward P/E | 12,63 |
| P/B Ratio | 1,68 | P/S Ratio | 0,41 |
| PEG Ratio | N/A | Forward PEG | 0,44 |
| EV/EBITDA | 13,70 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,39 | Fwd Earnings Yield | 7,92% |
| FCF Yield | 2,32% | ||
| Market Cap | 372,80 M | Enterprise Value | 446,29 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,16 | Revenue / Share | 11,87 |
| FCF / Share | 0,11 | OCF / Share | 0,17 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | -28,44% |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,50% | FCF Conversion | 64,84% |
| SBC-Adj. FCF | 5,61 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 917,93 M | 965,26 M | 1,22 B | 1,34 B | — |
| Net Income | 13,34 M | -58,98 M | -28,01 M | -41,60 M | 46,08 M |
| EPS (Diluted) | 0,16 | -0,82 | -0,40 | -0,60 | 0,61 |
| Gross Profit | 34,91 M | 9,72 M | 15,65 M | -27,55 M | 67,78 M |
| Operating Income | 7,36 M | -51,68 M | -23,85 M | -61,36 M | 40,07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 27,21 M | 29,74 M | 32,66 M | 31,58 M | 29,19 M |
| D&A | 25,22 M | 24,41 M | 23,08 M | — | — |
| Interest Expense | 10,77 M | — | 7,43 M | -1,83 M | 3,59 M |
| Income Tax | -621 000,0 | 173 000,0 | 97 000,0 | 1,93 M | 1,47 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 388,79 M | 401,44 M | 454,24 M | 478,32 M | 484,95 M |
| Total Liabilities | 143,55 M | 176,38 M | 174,68 M | 170,23 M | 139,74 M |
| Shareholders' Equity | 245,24 M | 225,06 M | 279,56 M | 308,09 M | 345,21 M |
| Total Debt | 84,59 M | 99,68 M | 90,69 M | 78,08 M | 50,40 M |
| Cash & Equivalents | 23,42 M | 35,47 M | 30,01 M | 36,46 M | 50,61 M |
| Current Assets | 155,92 M | 153,12 M | 168,77 M | 199,12 M | 229,53 M |
| Current Liabilities | 59,07 M | 57,80 M | 65,29 M | 78,02 M | 69,60 M |
{"event":"ticker_viewed","properties":{"ticker":"ALTO","listing_kind":"stock","pathname":"/stocks/alto","exchange":"NASDAQ","country":"US"}}